Clinical trial
The Potential Protective Effect of a Formula Supplemented With Fermented Matrices on the Risk of Developing Neonatal Sepsis
NCT04742582 is registered in ClinicalTrials.gov with Heinz Italia SpA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Potential Protective Effect of a Formula Supplemented With Fermented Matrices on the Risk of Developing Neonatal Sepsis
- Lead sponsor
- Heinz Italia SpA
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 1, 2021
- Completion date
- February 1, 2024
- Enrollment
- 876 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.